| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8740750 | Journal of Infection and Chemotherapy | 2018 | 5 Pages |
Abstract
Our data showed that MBI-LCBI cases account for 45.5% of the CLABSI cases identified in blood cancer patients, and constituted a significant burden to this high-risk patient population.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Yukiko Kato, Mao Hagihara, Ai Kurumiya, Tomoko Takahashi, Miki Sakata, Yuichi Shibata, Hideo Kato, Arufumi Shiota, Hiroki Watanabe, Nobuhiro Asai, Yusuke Koizumi, Yuka Yamagishi, Hiroshige Mikamo,